Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize

Michal Kýr; Giannoula Lakka Klement; Lenka Zdrazilova-Dubska; Regina Demlova; Dalibor Valik; Ondrej Slaby; Irene Slavc; Jaroslav Sterba

doi:10.3389/fonc.2020.00377

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize

Front Oncol. 2020 Mar 24:10:377. doi: 10.3389/fonc.2020.00377. eCollection 2020.

Authors

Michal Kýr^{1

2}, Giannoula Lakka Klement^{1

3

4}, Lenka Zdrazilova-Dubska^{5

6}, Regina Demlova^{6

7}, Dalibor Valik^{1

5

6}, Ondrej Slaby^{8

9}, Irene Slavc¹⁰, Jaroslav Sterba^{1

2}

Affiliations

¹ Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia.
² Faculty of Medicine, Masaryk University, Brno, Czechia.
³ CSTS Health Care, Toronto, ON, Canada.
⁴ Floating Hospital for Children at Tufts Medical Center, Boston, MA, United States.
⁵ Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czechia.
⁶ Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czechia.
⁷ Department of Clinical Trials, Masaryk Memorial Cancer Institute, Brno, Czechia.
⁸ Department of Pathology, University Hospital Brno, Brno, Czechia.
⁹ Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czechia.
¹⁰ Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

No abstract available

Keywords: clinical trial designs; drug models; pediatric oncology; personalized medicine; personalized precision pediatric oncology; precision oncology; trial models.

Publication types

Editorial